Idarubicin-loaded degradable hydrogel for TACE therapy enhances anti-tumor immunity in hepatocellular carcinoma

Idarubicin-loaded degradable hydrogel for TACE therapy enhances anti-tumor immunity in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a common and deadly cancer, often diagnosed at advanced stages, limiting surgical options. Transcatheter arterial chemoembolization (TACE) is a primary treatment for inoperable and involves the use of drug-eluting microspheres to slowly release chemotherapy drugs. H...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaokai Zhang, Xiujiao Deng, Jizhou Tan, Haikuan Liu, Hong Zhang, Chengzhi Li, Qingjun Li, Jinxue Zhou, Zeyu Xiao, Jiaping Li
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Materials Today Bio
Subjects:
Hepatocellular carcinoma
Transarterial chemoembolization
Immunogenic cell death
Idarubicin
Composite hydrogel
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006424004046
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items